These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 28180146)
1. "I think we've got too many tests!": Prenatal providers' reflections on ethical and clinical challenges in the practice integration of cell-free DNA screening. Gammon BL; Kraft SA; Michie M; Allyse M Ethics Med Public Health; 2016; 2(3):334-342. PubMed ID: 28180146 [TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
4. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals. Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550 [TBL] [Abstract][Full Text] [Related]
6. The personal utility of cfDNA screening: Pregnant patients' experiences with cfDNA screening and views on expanded cfDNA panels. Farrell RM; Agatisa PK; Michie MM; Greene A; Ford PJ J Genet Couns; 2020 Feb; 29(1):88-96. PubMed ID: 31680382 [TBL] [Abstract][Full Text] [Related]
7. Spanish- and English-Speaking Pregnant Women's Views on cfDNA and Other Prenatal Screening: Practical and Ethical Reflections. Floyd E; Allyse MA; Michie M J Genet Couns; 2016 Oct; 25(5):965-77. PubMed ID: 26739840 [TBL] [Abstract][Full Text] [Related]
8. Patient experiences with prenatal cell-free DNA screening in a safety net setting. Riggan KA; Barwise A; Yap JQ; Condon N; Allyse MA Prenat Diagn; 2024 Apr; 44(4):409-417. PubMed ID: 38423995 [TBL] [Abstract][Full Text] [Related]
9. Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers. Benachi A; Caffrey J; Calda P; Carreras E; Jani JC; Kilby MD; Klein HG; Rizzo G; Yaron Y Eur J Med Genet; 2020 Jan; 63(1):103616. PubMed ID: 30654154 [TBL] [Abstract][Full Text] [Related]
10. Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians. Agatisa PK; Mercer MB; Coleridge M; Farrell RM J Genet Couns; 2018 Dec; 27(6):1374-1385. PubMed ID: 29951719 [TBL] [Abstract][Full Text] [Related]
11. Obstetrical provider knowledge and attitudes towards cell-free DNA screening: results of a cross-sectional national survey. Chan WV; Johnson JA; Wilson RD; Metcalfe A BMC Pregnancy Childbirth; 2018 Jan; 18(1):40. PubMed ID: 29361931 [TBL] [Abstract][Full Text] [Related]
12. Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol. MacKinnon K; Marcellus L; Rivers J; Gordon C; Ryan M; Butcher D JBI Database System Rev Implement Rep; 2015 Jan; 13(1):14-26. PubMed ID: 26447004 [TBL] [Abstract][Full Text] [Related]
13. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings. Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528 [TBL] [Abstract][Full Text] [Related]
14. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening. Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086 [TBL] [Abstract][Full Text] [Related]
15. Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec. Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V BMC Med Ethics; 2020 Feb; 21(1):15. PubMed ID: 32041603 [TBL] [Abstract][Full Text] [Related]
16. Expanding Use of cfDNA Screening in Pregnancy: Current and Emerging Ethical, Legal, and Social Issues. Parham L; Michie M; Allyse M Curr Genet Med Rep; 2017 Mar; 5(1):44-53. PubMed ID: 38089918 [TBL] [Abstract][Full Text] [Related]
17. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test. Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918 [TBL] [Abstract][Full Text] [Related]
18. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study. Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225 [TBL] [Abstract][Full Text] [Related]
19. Cell-free fetal DNA screening for detection of microdeletion syndromes: a cost-effectiveness analysis. Avram CM; Shaffer BL; Sparks TN; Allen AJ; Caughey AB J Matern Fetal Neonatal Med; 2021 Jun; 34(11):1732-1740. PubMed ID: 31327283 [TBL] [Abstract][Full Text] [Related]
20. Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues. Gekas J; Langlois S; Ravitsky V; Audibert F; van den Berg DG; Haidar H; Rousseau F Appl Clin Genet; 2016; 9():15-26. PubMed ID: 26893576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]